The pharmaceutical landscape is seeing a change with the arrival of GLP-1 transdermal systems . These innovative formulations offer a possible alternative to providing glucagon-like peptide-1 drugs for https://junaidbckh346995.ezblogz.com/72738852/glp-1-patches-a-novel-way-to-control-blood-sugar